Literature DB >> 19220360

Fitness cost of drug resistance in Mycobacterium tuberculosis.

S Gagneux1.   

Abstract

Multidrug-resistant (MDR)--and extensively drug-resistant (XDR)--forms of tuberculosis are growing public health problems. Mathematical models predict that the future of the MDR and XDR tuberculosis epidemics depends in part on the competitive fitness of drug-resistant strains. Here, recent experimental and molecular epidemiological data that illustrate how heterogeneity among drug-resistant strains of Mycobacterium tuberculosis can influence the relative fitness and transmission of this pathogen are reviewed.

Entities:  

Mesh：

Year:  2009        PMID： 19220360     DOI： 10.1111/j.1469-0691.2008.02685.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  41 in total

1.  Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand.

Authors:  Sanjib Mani Regmi; Angkana Chaiprasert; Supasak Kulawonganunchai; Sissades Tongsima; Olabisi Oluwabukola Coker; Therdsak Prammananan; Wasna Viratyosin; Iyarit Thaipisuttikul
Journal:  Mol Genet Genomics       Date:  2015-04-24       Impact factor: 3.291

2.  Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.

Authors:  Hao Li; Masood ur Rehman Kayani; Yunting Gu; Xiaobo Wang; Ting Zhu; Hongfei Duan; Yifeng Ma; Hairong Huang; Babak Javid
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

3.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

4.  Source of the Fitness Defect in Rifamycin-Resistant Mycobacterium tuberculosis RNA Polymerase and the Mechanism of Compensation by Mutations in the β' Subunit.

Authors:  Maxwell A Stefan; Fatima S Ugur; George A Garcia
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

5.  Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype.

Authors:  Andrea von Groll; Anandi Martin; Matthias Stehr; Mahavir Singh; Françoise Portaels; Pedro Eduardo Almeida da Silva; Juan Carlos Palomino
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

6.  Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria.

Authors:  Lana Dinic; Patrick Akande; Emmanuel Oni Idigbe; Agatha Ani; Dan Onwujekwe; Oche Agbaji; Maxwell Akanbi; Rita Nwosu; Bukola Adeniyi; Maureen Wahab; Chindak Lekuk; Chioma Kunle-Ope; Nkiru Nwokoye; Phyllis Kanki
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

7.  Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.

Authors:  M de Vos; B Müller; S Borrell; P A Black; P D van Helden; R M Warren; S Gagneux; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

8.  Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis.

Authors:  Gregory P Bisson; Carolina Mehaffy; Corey Broeckling; Jessica Prenni; Dalin Rifat; Desmond S Lun; Marcos Burgos; Drew Weissman; Petros C Karakousis; Karen Dobos
Journal:  J Bacteriol       Date:  2012-09-21       Impact factor: 3.490

9.  A model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its future.

Authors:  Bruce R Levin; Fernando Baquero; Pål J Johnsen
Journal:  Curr Opin Microbiol       Date:  2014-07-11       Impact factor: 7.934

Review 10.  Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.